betterlife pharma.png
BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives
September 27, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 27, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife and Collaborators to Submit Key Joint Research Publication
September 07, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects
August 24, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, Aug. 24, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), is an emerging biotech company focused...
betterlife pharma.png
BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies
July 06, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference
June 23, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Federation of European Neuroscience Societies (FENS) Forum
June 21, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
betterlife pharma.png
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference
April 21, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife New Logo.png
BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression
April 06, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife New Logo.png
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity in Preclinical Model
February 15, 2022 08:00 ET | BetterLife Pharma Inc.
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
GPM Logo.jpg
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nano-X Imaging Ltd. (NNOX)
October 28, 2021 14:40 ET | Glancy Prongay & Murray LLP
LOS ANGELES, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 6, 2021 deadline to file a lead plaintiff motion in the class action...